ThinkGP live webinar – A new role for SGLT2 inhibitors in the management of HFrEF

This webinar will discuss important new guideline updates regarding diagnosis and treatment optimisation for people with heart failure with reduced ejection fraction (HFrEF), including the role that sodium-glucose transport 2 inhibitors (SGLT2i) play in first-line management.

Recommendations have been rapidly changing in this area, including management implications for GPs. Join Dr Chee Khoo as he takes a practical, contemporary look at early diagnosis, treatment and management of people with HFrEF.